Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission

ADVERTISEMENT

Click to copy

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

Click to copy

Related topics

Oxford Cannabinoid Technologies “ready to go” after phase 1 trial submission

PRESS RELEASE: Paid content from News Direct Corporation

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

January 6, 2023 GMT

None

None

--News Direct--

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) chief scientific officer Dr Valentino Parravicini speaks to Proactive after submitting a phase 1 trial application for its lead programme (OCT461201) to the UK Medicines & Healthcare products Regulatory Agency (MHRA) and Wales Research Ethics Committee (REC). Parravicini says that the submission demonstrates that the company is “ready to go” in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View original content to download multimedia: https://newsdirect.com/news/oxford-cannabinoid-technologies-ready-to-go-after-phase-1-trial-submission-880021630